サンプル依頼リスト カート
  • English
  • Korean
表紙：内視鏡的逆行性胆管膵管造影（ERCP）の世界市場規模調査＆予測：製品タイプ別、用途別、エンドユーザー別、地域別分析、2023-2030年
市場調査レポート
商品コード
1303528

内視鏡的逆行性胆管膵管造影（ERCP）の世界市場規模調査＆予測：製品タイプ別、用途別、エンドユーザー別、地域別分析、2023-2030年

Global Endoscopic Retrograde Cholangiopancreatography Market Size study & Forecast, by Product Type, by Application, by End-User and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
内視鏡的逆行性胆管膵管造影（ERCP）の世界市場規模調査＆予測：製品タイプ別、用途別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年07月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

内視鏡検査は、特定の小手術を行ったり、体内の組織や内臓を注意深く検査したりするために用いられる医療処置です。

内視鏡的逆行性胆管膵管造影（ERCP）は、膵臓や胆道系に関連する疾患のために作られた医療器具です。バレット病、胆道疾患、クローン病、大腸炎、胃食道逆流症（GERD）、膵炎、炎症性腸疾患、肝疾患、クローン病、消化性潰瘍性疾患など、さまざまな胆管、膵臓、肝臓疾患の有病率の増加により、これらの機器はますます重要になるとともに、使用頻度も高くなっています。がんの罹患率の上昇、内視鏡研究を改善するための政府や医療組織による投資、資金、助成金の増加、低侵襲手術への嗜好の高まりなどの主な要因は、予測期間中に市場に有利な需要を創出すると予想されています。

さらに、膵臓がんの有病率の上昇は、内視鏡的逆行性胆管膵管造影（ERCP）市場の成長を促進する要因の1つです。ERCPは、膵臓がんを含む胆管・膵管の疾患の診断・治療に用いられる手技です。米国臨床腫瘍学会（ASCO）によると、2021年9月、米国では男性31,950人、女性28,480人が膵臓がんと診断されました。この疾患はがん全体の約3％に寄与しています。膵臓がんは、男性では10番目に多い疾患であり、女性では8番目に多いがんです。膵臓がんの症例は毎年約1％多く報告されています。膵臓がんの発生率が増加するにつれて、ERCPのような診断・治療手技の必要性が高まっています。ERCPは、低侵襲的アプローチによって、膵臓がんなどの膵臓・胆道疾患の可視化と治療を可能にします。さらに、病院による高度な内視鏡検査機器への投資への注目の高まりや、シングルユース内視鏡検査機器の採用の高まりは、予測期間中に市場に有利な機会を創出すると予想されています。しかし、内視鏡的逆行性胆管膵管造影（ERCP）の高コストは、2023-2030年の予測期間を通じて市場の成長を抑制します。

内視鏡的逆行性胆管膵管造影（ERCP）の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、主要な市場プレイヤーの存在、がんの有病率の上昇、同地域における製品の革新と開発により、2022年の市場を独占しました。アジア太平洋地域は、消化器疾患や慢性胆道疾患の増加、肝臓や膵臓の良性腫瘍の頻度上昇、同地域の高齢化などの要因により、予測期間中に大きく成長すると予想されます。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 内視鏡的逆行性胆管膵管造影（ERCP）市場：地域別、2020～2030年
    • 内視鏡的逆行性胆管膵管造影（ERCP）市場：製品タイプ別、2020-2030年
    • 内視鏡的逆行性胆管膵管造影（ERCP）市場：用途別、2020-2030年
    • 内視鏡的逆行性胆管膵管造影（ERCP）市場：エンドユーザー別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場定義と調査範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場力学

  • 内視鏡的逆行性胆管膵管造影（ERCP）の市場影響分析（2020-2030年）
    • 市場促進要因
      • がん罹患率の上昇
      • 政府や医療機関による内視鏡研究向上のための投資、資金、助成金の増加
      • 低侵襲手術への嗜好の高まり
    • 市場の課題
      • 内視鏡的逆行性胆管膵管造影（ERCP）のコスト高
    • 市場機会
      • 病院による先進的内視鏡機器への投資への注目の高まり
      • 使い捨て内視鏡器具の採用拡大

第4章 世界の内視鏡的逆行性胆管膵管造影（ERCP）市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：製品タイプ別

  • 市場スナップショット
  • 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：製品タイプ別、実績 - ポテンシャル分析
  • 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：製品タイプ別推定・予測、2020-2030年
  • 内視鏡的逆行性胆管膵管造影（ERCP）の市場、サブセグメント分析
    • 内視鏡
    • 内視鏡治療デバイス
    • イメージングデバイス
    • エネルギーデバイス
    • その他

第6章 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：用途別

  • 市場スナップショット
  • 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：用途別、業績、潜在能力分析
  • 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：用途別推定・予測、2020-2030年
  • 内視鏡的逆行性胆管膵管造影（ERCP）の市場、サブセグメント別分析
    • 胆道括約筋切開術
    • 胆道拡張術
    • 胆道ステント留置術
    • 膵括約筋切開術
    • 膵管拡張術
    • 膵管ステント留置術

第7章 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：エンドユーザー別

  • 市場スナップショット
  • 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：エンドユーザー別、業績-潜在能力分析
  • 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：エンドユーザー別推定・予測、2020-2030年
  • 内視鏡的逆行性胆管膵管造影（ERCP）市場、サブセグメント分析
    • 病院・クリニック
    • 外来手術センター
    • その他

第8章 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 内視鏡的逆行性胆管膵管造影（ERCP）の世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品タイプの推定・予測、2020-2030年
      • 用途の推定・予測、2020-2030年
      • エンドユーザー別の推定・予測、2020～2030年
    • カナダ
  • 欧州の内視鏡的逆行性胆管膵管造影（ERCP）市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の内視鏡的逆行性胆管膵管造影（ERCP）市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの内視鏡的逆行性胆管膵管造影（ERCP）市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Olympus Corporation（Japan）
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • CONMED Corporation（US）
    • Fujifilm Holdings Corporation（Japan）
    • HOYA Corporation（Japan）
    • KARL STORZ SE & Co. KG（Germany）
    • Ambu A/S（Denmark）
    • Boston Scientific Corporation（US）
    • Johnson & Johnson（US）
    • Medtronic, PLC（Ireland）
    • Cook Medical（US）

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Endoscopic Retrograde Cholangiopancreatography Market, report scope
  • TABLE 2. Global Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by Product Type 2020-2030 (USD Billion)
  • TABLE 4. Global Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by End-User 2020-2030 (USD Billion)
  • TABLE 6. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Endoscopic Retrograde Cholangiopancreatography Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Endoscopic Retrograde Cholangiopancreatography Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Endoscopic Retrograde Cholangiopancreatography Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Endoscopic Retrograde Cholangiopancreatography Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Endoscopic Retrograde Cholangiopancreatography Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Endoscopic Retrograde Cholangiopancreatography Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Endoscopic Retrograde Cholangiopancreatography Market
  • TABLE 71. List of primary sources, used in the study of global Endoscopic Retrograde Cholangiopancreatography Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Endoscopic Retrograde Cholangiopancreatography Market, research methodology
  • FIG 2. Global Endoscopic Retrograde Cholangiopancreatography Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Endoscopic Retrograde Cholangiopancreatography Market, key trends 2022
  • FIG 5. Global Endoscopic Retrograde Cholangiopancreatography Market, growth prospects 2023-2030
  • FIG 6. Global Endoscopic Retrograde Cholangiopancreatography Market, porters 5 force model
  • FIG 7. Global Endoscopic Retrograde Cholangiopancreatography Market, pest analysis
  • FIG 8. Global Endoscopic Retrograde Cholangiopancreatography Market, value chain analysis
  • FIG 9. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Endoscopic Retrograde Cholangiopancreatography Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Endoscopic Retrograde Cholangiopancreatography Market, regional snapshot 2020 & 2030
  • FIG 15. North America Endoscopic Retrograde Cholangiopancreatography Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Endoscopic Retrograde Cholangiopancreatography Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Endoscopic Retrograde Cholangiopancreatography Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Endoscopic Retrograde Cholangiopancreatography Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2023-2030. Endoscopy is a medical procedure used to do certain minor surgery or to carefully examine tissues in the body or internal organs. Devices for endoscopic retrograde cholangiopancreatography (ERCP) are medical tools made for diseases relating to the pancreas and biliary system. Due to an increase in the prevalence of various bile duct, pancreatic, and liver disorders like Barrett's disease, biliary disease, Crohn's disease, colitis, gastroesophageal reflux disorder (GERD), pancreatitis, inflammatory bowel disease, liver disease, Crohn's disease, and peptic ulcer disease, these devices are becoming more and more important as well as used more frequently. The key factors such as rising incidence of cancer, rising investments, funds, and grants by governments and healthcare organizations to improve endoscopy research, and growing preference for minimally invasive surgeries are anticipated to create a lucrative demand for the market during forecast period.

Moreover, the rising prevalence of pancreatic cancer is one of the factors driving the growth of the Endoscopic Retrograde Cholangiopancreatography (ERCP) market. ERCP is a procedure used to diagnose and treat diseases of the bile and pancreatic ducts, including pancreatic cancer. According to the American Society of Clinical Oncology (ASCO), in Sept. 2021, pancreatic cancer was diagnosed in 31,950 men and 28,480 women in the United States. This disorder contributes to about 3% of all cancers. Pancreatic cancer is the tenth most common disease in males and the eighth most common cancer in women. About 1% more cases of pancreatic cancer are reported annually. As the incidence of pancreatic cancer increases, there is a growing need for diagnostic and therapeutic procedures such as ERCP. ERCP allows for the visualization and treatment of pancreatic and biliary diseases, such as pancreatic cancer, through a minimally invasive approach. Additionally, rising focus on investments by hospitals for advanced endoscopy instruments and rising adoption of single-use endoscopy instruments are anticipated to create a lucrative opportunity for the market during the forecast period. However, the high cost of Endoscopic Retrograde Cholangiopancreatography stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Endoscopic Retrograde Cholangiopancreatography Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising prevalence of cancer, and product innovation and development in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as increase in incidences of gastrointestinal and chronic biliary disorders, rising frequencies of benign tumors of the liver and pancreas, growing ageing population in the region.

Major market players included in this report are:

  • Olympus Corporation (Japan)
  • CONMED Corporation (US)
  • Fujifilm Holdings Corporation (Japan)
  • HOYA Corporation (Japan)
  • KARL STORZ SE & Co. KG (Germany)
  • Ambu A/S (Denmark)
  • Boston Scientific Corporation (US)
  • Johnson & Johnson (US)
  • Medtronic, PLC (Ireland)
  • Cook Medical (US)

Recent Developments in the Market:

  • In Jan. 2022, An endoscopic clipping tool named Instinct Plus was launched by Cook Medical (US). It is compatible with a duodenoscope and has uses in the GI tract for prophylactic clipping, anchoring treatments, and defect closure.

Global Endoscopic Retrograde Cholangiopancreatography Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product Type, Application, End-User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product Type:

  • Endoscopes
  • Endotherapy Devices
  • Imaging Devices
  • Energy Devices
  • Others

By Application:

  • Biliary Sphincterotomy
  • Biliary Dilatation
  • Biliary Stenting
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Dilatation
  • Pancreatic Duct Stenting

By End-User:

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Endoscopic Retrograde Cholangiopancreatography Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Endoscopic Retrograde Cholangiopancreatography Market, by Product Type, 2020-2030 (USD Billion)
    • 1.2.3. Endoscopic Retrograde Cholangiopancreatography Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Endoscopic Retrograde Cholangiopancreatography Market, by End-User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Endoscopic Retrograde Cholangiopancreatography Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Endoscopic Retrograde Cholangiopancreatography Market Dynamics

  • 3.1. Endoscopic Retrograde Cholangiopancreatography Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising incidence of cancer
      • 3.1.1.2. Rising investments, funds, and grants by governments and healthcare organizations to improve endoscopy research
      • 3.1.1.3. Growing preference for minimally invasive surgeries
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of Endoscopic Retrograde Cholangiopancreatography
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising focus on investments by hospitals for advanced endoscopy instruments
      • 3.1.3.2. Growing adoption of single-use endoscopy instruments

Chapter 4. Global Endoscopic Retrograde Cholangiopancreatography Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Endoscopic Retrograde Cholangiopancreatography Market, by Product Type

  • 5.1. Market Snapshot
  • 5.2. Global Endoscopic Retrograde Cholangiopancreatography Market by Product Type, Performance - Potential Analysis
  • 5.3. Global Endoscopic Retrograde Cholangiopancreatography Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
  • 5.4. Endoscopic Retrograde Cholangiopancreatography Market, Sub Segment Analysis
    • 5.4.1. Endoscopes
    • 5.4.2. Endotherapy Devices
    • 5.4.3. Imaging Devices
    • 5.4.4. Energy Devices
    • 5.4.5. Others

Chapter 6. Global Endoscopic Retrograde Cholangiopancreatography Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Endoscopic Retrograde Cholangiopancreatography Market by Application, Performance - Potential Analysis
  • 6.3. Global Endoscopic Retrograde Cholangiopancreatography Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Endoscopic Retrograde Cholangiopancreatography Market, Sub Segment Analysis
    • 6.4.1. Biliary Sphincterotomy
    • 6.4.2. Biliary Dilatation
    • 6.4.3. Biliary Stenting
    • 6.4.4. Pancreatic Sphincterotomy
    • 6.4.5. Pancreatic Duct Dilatation
    • 6.4.6. Pancreatic Duct Stenting

Chapter 7. Global Endoscopic Retrograde Cholangiopancreatography Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Endoscopic Retrograde Cholangiopancreatography Market by End-User, Performance - Potential Analysis
  • 7.3. Global Endoscopic Retrograde Cholangiopancreatography Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
  • 7.4. Endoscopic Retrograde Cholangiopancreatography Market, Sub Segment Analysis
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Ambulatory Surgery Centers
    • 7.4.3. Others

Chapter 8. Global Endoscopic Retrograde Cholangiopancreatography Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Endoscopic Retrograde Cholangiopancreatography Market, Regional Market Snapshot
  • 8.4. North America Endoscopic Retrograde Cholangiopancreatography Market
    • 8.4.1. U.S. Endoscopic Retrograde Cholangiopancreatography Market
      • 8.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End-User breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Endoscopic Retrograde Cholangiopancreatography Market
  • 8.5. Europe Endoscopic Retrograde Cholangiopancreatography Market Snapshot
    • 8.5.1. U.K. Endoscopic Retrograde Cholangiopancreatography Market
    • 8.5.2. Germany Endoscopic Retrograde Cholangiopancreatography Market
    • 8.5.3. France Endoscopic Retrograde Cholangiopancreatography Market
    • 8.5.4. Spain Endoscopic Retrograde Cholangiopancreatography Market
    • 8.5.5. Italy Endoscopic Retrograde Cholangiopancreatography Market
    • 8.5.6. Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market
  • 8.6. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market Snapshot
    • 8.6.1. China Endoscopic Retrograde Cholangiopancreatography Market
    • 8.6.2. India Endoscopic Retrograde Cholangiopancreatography Market
    • 8.6.3. Japan Endoscopic Retrograde Cholangiopancreatography Market
    • 8.6.4. Australia Endoscopic Retrograde Cholangiopancreatography Market
    • 8.6.5. South Korea Endoscopic Retrograde Cholangiopancreatography Market
    • 8.6.6. Rest of Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market
  • 8.7. Latin America Endoscopic Retrograde Cholangiopancreatography Market Snapshot
    • 8.7.1. Brazil Endoscopic Retrograde Cholangiopancreatography Market
    • 8.7.2. Mexico Endoscopic Retrograde Cholangiopancreatography Market
  • 8.8. Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market
    • 8.8.1. Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market
    • 8.8.2. South Africa Endoscopic Retrograde Cholangiopancreatography Market
    • 8.8.3. Rest of Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Olympus Corporation (Japan)
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. CONMED Corporation (US)
    • 9.3.3. Fujifilm Holdings Corporation (Japan)
    • 9.3.4. HOYA Corporation (Japan)
    • 9.3.5. KARL STORZ SE & Co. KG (Germany)
    • 9.3.6. Ambu A/S (Denmark)
    • 9.3.7. Boston Scientific Corporation (US)
    • 9.3.8. Johnson & Johnson (US)
    • 9.3.9. Medtronic, PLC (Ireland)
    • 9.3.10. Cook Medical (US)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption